- Q1 2024 Abcellera Biologics Inc Earnings Call TranscriptMay 07, 2024€3.8 (+1.50%)Earnings
- Q4 2023 Abcellera Biologics Inc Earnings Call TranscriptFeb 20, 2024€4.87 (+0.04%)Earnings
- Abcellera Biologics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Abcellera Biologics Inc Earnings Call TranscriptNov 02, 2023€4.15 (+7.62%)Earnings
- Q2 2023 Abcellera Biologics Inc Earnings Call TranscriptAug 03, 2023€6.35 (-0.56%)Earnings
- Abcellera Biologics Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Q1 2023 Abcellera Biologics Inc Earnings Call TranscriptMay 04, 2023€5.77 (-2.73%)Earnings
- Abcellera Biologics Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Q4 2022 Abcellera Biologics Inc Earnings Call TranscriptFeb 21, 2023€8.38 (-6.11%)Earnings
- Abcellera Biologics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Abcellera Biologics Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Abcellera Biologics Inc Earnings Call TranscriptNov 08, 2022€11.92 (+0.39%)Earnings
- Q2 2022 Abcellera Biologics Inc Earnings Call TranscriptAug 09, 2022€10.79 (-6.80%)Earnings
- Q1 2022 Abcellera Biologics Inc Earnings Call TranscriptMay 10, 2022€6.43 (+2.08%)Earnings
- Abcellera Biologics Inc at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 02, 2022
- Q4 2021 Abcellera Biologics Inc Earnings Call TranscriptFeb 24, 2022€6.96 (-5.95%)Earnings
- Abcellera Biologics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Q3 2021 Abcellera Biologics Inc Earnings Call TranscriptNov 09, 2021€12.85 (-2.65%)Earnings
- Abcellera Biologics Inc at Bank of America Tech Solutions for Drug Discovery Conference (Virtual) TranscriptSep 20, 2021
- Q2 2021 Abcellera Biologics Inc Earnings Call TranscriptAug 12, 2021Earnings
- Q1 2021 Abcellera Biologics Inc Earnings Call TranscriptMay 13, 2021Earnings
- Q4 2020 Abcellera Biologics Inc Earnings Call TranscriptMar 29, 2021Earnings
Q4 2023 Abcellera Biologics Inc Earnings Call Transcript
Good afternoon, and thank you for attending the AbCellera Biologics Inc. FY 2023 earnings results and business update call. My name is Matt, and I'll be your moderator for today's call. (Operator Instructions)
I would now like to pass the conference over to our host, Tryn Stimart, Chief Legal and Compliance Officer with AbCellera. Please go ahead.
Thank you. Good morning, good afternoon, and good evening to everyone listening around the world. Thank you for joining us for AbCellera's full-year 2023 earnings call. I'm Tryn Stimart, AbCellera's Chief Legal and Compliance Officer. Joining me on today's call are Dr. Carl Hansen, AbCellera's President and Chief Executive Officer; and Andrew Booth, AbCellera's Chief Financial Officer.
During this call, we anticipate making projections and forward-looking statements based on our current expectations and pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Our actual results could
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)